H. Pylori

Our clinical trial for H. Pylori is now open to enrollment. Qualified patients may receive study medication provided at no cost, treatment by licensed physicians, and compensation for time and travel.

Click to Download the H. Pylori Study Brochure

Basic Inclusion Criteria:

  1. Males or females between 18 to 70 years of age
  2. Symptoms consistent with dyspepsia of at least two weeks duration (defined as recurrent pain or discomfort centered in the upper abdomen, often with a relation to meals)
  3. Agrees to refrain from taking antacids or H2 blockers from screening through day 15
  4. Provide written informed consent to participate as shown by a signature of subject on the consent form

Basic Exclusion Criteria:

  1. Have received prior H. pylori eradication therapy
  2. Have alarm symptoms/signs (including unexplained anemia [iron deficiency], melena / hematemesis, anorexia, dysphagia, jaundice, weight loss)
  3. History of gastric cancer
  4. History of esophageal or gastric surgery, except for simple closure of perforated ulcer
  5. Unable to communicate well with the Investigators and to comply with the study requirements


Please note additional Inclusion / Exclusion criteria may apply. Please contact our Research Team to learn more! (616) 328-5344